HK1039449A1 - 治療多發性硬化的方法 - Google Patents
治療多發性硬化的方法Info
- Publication number
- HK1039449A1 HK1039449A1 HK02100531.4A HK02100531A HK1039449A1 HK 1039449 A1 HK1039449 A1 HK 1039449A1 HK 02100531 A HK02100531 A HK 02100531A HK 1039449 A1 HK1039449 A1 HK 1039449A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- multiple sclerosis
- treating multiple
- treating
- sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10374298P | 1998-10-09 | 1998-10-09 | |
PCT/US1999/023482 WO2000021513A2 (en) | 1998-10-09 | 1999-10-08 | Methods for treating multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1039449A1 true HK1039449A1 (zh) | 2002-04-26 |
Family
ID=22296795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02100531.4A HK1039449A1 (zh) | 1998-10-09 | 2002-01-23 | 治療多發性硬化的方法 |
Country Status (6)
Country | Link |
---|---|
US (3) | US6492427B2 (zh) |
EP (1) | EP1117391A2 (zh) |
AU (1) | AU1105800A (zh) |
CA (1) | CA2346773A1 (zh) |
HK (1) | HK1039449A1 (zh) |
WO (1) | WO2000021513A2 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156535A (en) * | 1995-08-04 | 2000-12-05 | University Of Ottawa | Mammalian IAP gene family, primers, probes, and detection methods |
US6133437A (en) * | 1997-02-13 | 2000-10-17 | Apoptogen, Inc. | Modulation of IAPs for the treatment of proliferative diseases |
US6492427B2 (en) * | 1998-10-09 | 2002-12-10 | L. Sai Latha Shankar | Methods for treating multiple sclerosis |
WO2001088834A2 (en) * | 2000-05-17 | 2001-11-22 | New York University | Method and system for data classification in the presence of a temporal non-stationarity |
US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
WO2005000203A2 (en) * | 2001-10-31 | 2005-01-06 | Sention, Inc. | Methods for treating cognitive impairment and improving cognition |
BR0308923A (pt) * | 2002-03-27 | 2005-01-04 | Aegera Therapeutics Inc | OligÈmeros de nucleobase de iap anti-sentido e empregos destes |
CN103540568A (zh) * | 2002-04-26 | 2014-01-29 | 米迪缪尼有限公司 | 制备流感病毒的多质粒*** |
US8012944B2 (en) * | 2003-10-30 | 2011-09-06 | Pharmascience Inc. | Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent |
CN101351544B (zh) * | 2005-08-26 | 2013-06-12 | 罗切斯特大学 | 胶质限制性前体衍生的星形胶质细胞移植以促进轴突生长 |
IS2385B (is) * | 2006-02-10 | 2008-07-15 | Actavis Group Hf. | Klópidógrel bísúlfat lyfjasamsetningar |
CN101358609A (zh) * | 2007-08-03 | 2009-02-04 | 富准精密工业(深圳)有限公司 | 风扇转子 |
WO2010054307A1 (en) * | 2008-11-07 | 2010-05-14 | The Cleveland Clinic Foundation | Compounds and methods of promoting oligodendrocyte precursor differentiation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844003A (en) * | 1991-04-04 | 1998-12-01 | Innovations Foundation | Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
US5767164A (en) * | 1991-04-04 | 1998-06-16 | Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
US5444095A (en) | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
US6348208B1 (en) * | 1995-01-13 | 2002-02-19 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
CN100360123C (zh) | 1995-01-13 | 2008-01-09 | 萨默塞特药品有限公司 | 应用去甲司来吉兰的方法和医药组合物 |
US5679715A (en) * | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
GB9600660D0 (en) | 1996-01-12 | 1996-03-13 | Ciba Geigy Ag | Protein |
US6492427B2 (en) * | 1998-10-09 | 2002-12-10 | L. Sai Latha Shankar | Methods for treating multiple sclerosis |
-
1999
- 1999-10-08 US US09/416,010 patent/US6492427B2/en not_active Expired - Fee Related
- 1999-10-08 EP EP99954796A patent/EP1117391A2/en not_active Withdrawn
- 1999-10-08 WO PCT/US1999/023482 patent/WO2000021513A2/en not_active Application Discontinuation
- 1999-10-08 CA CA002346773A patent/CA2346773A1/en not_active Abandoned
- 1999-10-08 AU AU11058/00A patent/AU1105800A/en not_active Abandoned
-
2002
- 2002-01-23 HK HK02100531.4A patent/HK1039449A1/zh unknown
- 2002-07-26 US US10/205,747 patent/US20030078295A1/en not_active Abandoned
-
2004
- 2004-03-23 US US10/807,911 patent/US20050004229A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000021513A3 (en) | 2000-08-24 |
US6492427B2 (en) | 2002-12-10 |
WO2000021513A9 (en) | 2000-10-12 |
US20020022661A1 (en) | 2002-02-21 |
US20050004229A1 (en) | 2005-01-06 |
WO2000021513A2 (en) | 2000-04-20 |
US20030078295A1 (en) | 2003-04-24 |
EP1117391A2 (en) | 2001-07-25 |
AU1105800A (en) | 2000-05-01 |
CA2346773A1 (en) | 2000-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142248A0 (en) | Methods for treating sepsis | |
HK1039449A1 (zh) | 治療多發性硬化的方法 | |
GB9809414D0 (en) | Method | |
GB0226147D0 (en) | Treatment for multiple sclerosis | |
GB9809776D0 (en) | Method | |
GB9814055D0 (en) | Method | |
GB9819764D0 (en) | Method | |
EP1043994A4 (en) | METHOD OF TREATING MULTIPLE SCLEROSIS | |
GB9819769D0 (en) | Method | |
GB9802475D0 (en) | Method | |
GB9817266D0 (en) | Method | |
GB9824321D0 (en) | Method | |
GB9821225D0 (en) | Method | |
GB9820185D0 (en) | Method | |
GB9809780D0 (en) | Method | |
GB9821038D0 (en) | Method | |
GB9809782D0 (en) | Method | |
GB9804355D0 (en) | Method | |
GB9823963D0 (en) | Method | |
GB9825374D0 (en) | Method | |
AU1167P (en) | Treat xTriticosecale | |
SG77621A1 (en) | Distribution method | |
GB9602269D0 (en) | Novel compounds and methods for treating multiple sclerosis | |
GB9813089D0 (en) | Method | |
GB9811185D0 (en) | Method |